Table 2 Association of biological sex with treatment choice within 30-days after a diagnosis of atrial fibrillation among elderly participants in the MarketScan database (2007–2015)

Any anticoagulant (vs. none)

 Events/N

37,574/135,850

36,805/139,767

 %

27.7

26.3

 Model 1^†

1 (ref.)

1.00 (0.98, 1.01)

 Model 2^††

1 (ref.)

0.94 (0.93, 0.96)

DOAC (vs. warfarin)

 Events/N

6821/37,574

6900/36,805

 %

18.2

18.7

 Model 1^†

1 (ref.)

1.04 (1.01, 1.07)

 Model 2^††

1 (ref.)

1.05 (1.01, 1.08)

Rhythm control (vs. rate)

 Events/N

17,232/60,053

15,722/67,638

 %

28.7

23.2

 Model 1^†

1 (ref.)

0.85 (0.83, 0.86)

 Model 2^††

1 (ref.)

0.94 (0.93, 0.96)